![](/img/cover-not-exists.png)
Multicenter Phase I Trial of the Mitogen-Activated Protein Kinase 1/2 Inhibitor BAY 86-9766 in Patients with Advanced Cancer
Weekes, C. D., Von Hoff, D. D., Adjei, A. A., Leffingwell, D. P., Eckhardt, S. G., Gore, L., Lewis, K. D., Weiss, G. J., Ramanathan, R. K., Dy, G. K., Ma, W. W., Sheedy, B., Iverson, C., Miner, J. N.,Volume:
19
Language:
english
Journal:
Clinical Cancer Research
DOI:
10.1158/1078-0432.CCR-12-3529
Date:
March, 2013
File:
PDF, 946 KB
english, 2013